Progress on Resistance Mechanisms of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus

Jiaxian Li; Juan Du; Xiyue Lin; Fukai Bao; Zhen Li; Dehua Liu

Article Contents

Article Navigation > Journal of Kunming Medical University > 2026 > Accepted Manuscript

Jiaxian Li, Juan Du, Xiyue Lin, Fukai Bao, Zhen Li, Dehua Liu. Progress on Resistance Mechanisms of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus[J]. Journal of Kunming Medical University.

Citation:

Jiaxian Li, Juan Du, Xiyue Lin, Fukai Bao, Zhen Li, Dehua Liu. Progress on Resistance Mechanisms of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus[J]. Journal of Kunming Medical University.

Citation:

PDF( 2800 KB)

Progress on Resistance Mechanisms of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus

1.
Kunming Medical University Haiyuan College，Kunming Yunnan 651700
2.
Laboratory Department，The First People’s Hospital of Kunming，Kunming Yunnan 650011，China

Abstract

Abstract

Heterogeneous vancomycin-intermediate Staphylococcus aureus （hVISA） harbors minor resistant subpopulations that routinely evade detection by conventional susceptibility testing and represent a principal driver of clinical failure in vancomycin-based therapy. This organism develops intermediate resistance through a multilayered regulatory network: crosstalk between the WalKR and GraSR two-component systems hyperactivates peptidoglycan biosynthesis, leading to pronounced cell wall thickening that serves as a physical barrier to antibiotic penetration. Under antimicrobial stress, the strain initiates metabolic reprogramming of amino acid and purine pathways; in parallel, the mgrA-agr regulatory axis, acting in concert with biofilm formation, synergistically enhances both resistance and virulence. Sustained vancomycin selection drives convergent evolution, generating stably transmissible resistant clones that simultaneously exhibit cross-resistance to lipoglycopeptides and collateral sensitivity to β-lactams. The population analysis profile-area under the curve （PAP-AUC） remains the reference standard for detection; however, its labor-intensive procedure limits rapid screening applications. Emerging techniques, particularly single-cell sequencing and CRISPR-Cas9-based genome-wide screening, offer new opportunities for dissecting the mechanisms of hVISA heteroresistance. On the basis of available evidence, this review proposes two conceptual models—the "cell wall stress-threshold response" model and the "metabolic burden-collateral sensitivity trade-off" model—to explain the emergence of resistant subpopulations and the collateral sensitivity phenotype, respectively. An integrative systems-biology approach to deciphering multilayer regulatory networks is expected to provide a theoretical framework for optimizing rapid diagnostic algorithms, identifying novel anti-staphylococcal targets, and formulating evidence-based infection control strategies.
- hVISA,
- Resistance mechanism,
- Convergent evolution,
- Multi-omics technique

FullText(HTML)

References(62)

References

[1]	Keikha M, Karbalaei M. Global distribution of heterogeneous vancomycin-intermediate Staphylococcus aureus strains (1997-2021): A systematic review and meta-analysis. J Glob Antimicrob Resist. 2024 Jun;37: 11-21.
[2]	Yang D, Gu M, Tang X, He L, Zhang J, Wang X, Hou Y, Cui Y, Chan L, Tian J, Liu M. The global scope of heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA): A meta-analysis of its clinical impact, molecular epidemiology, and diagnostic challenges across 15, 165 isolates. BMC Infect Dis. 2026 Jun 6;26(1): 1425.
[3]	Cui L, Ma X, Sato K, Okuma K, Tenover FC, Mamizuka EM, Gemmell CG, Kim MN, Ploy MC, El-Solh N, Ferraz V, Hiramatsu K. Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J Clin Microbiol. 2003 Jan;41(1): 5-14.
[4]	Tawfeek C E, Khattab S, Elmaraghy N, Heiba A A, Nageeb WM. Reduced vancomycin susceptibility in Staphylococcus aureus clinical isolates: A spectrum of less investigated uncertainties. BMC Infect Dis. 2024 Oct 29;24(1): 1218.
[5]	Cui J, Zhang H, Mo Z, et al. Cell wall thickness and the molecular mechanism of heterogeneous vancomycin-intermediate Staphylococcus aureus[J]. Letters in applied microbiology, 2021, 72(5): 604-609.
[6]	Xu W, Yan P, Li Y, Sun B. The toxin-antitoxin system SavRS contributes to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus by mediating cell wall thickening[J]. J Antimicrob Chemother, 2025, 80(11): 2978-2988.
[7]	Laborda Anadón S. Membrane depolarisation induced by cell wall-targeting antibiotics triggers bactericidal activity independent of cell lysis[D]. Newcastle: Newcastle University, 2023.
[8]	Howden B P, Peleg A Y, Stinear T P. The evolution of vancomycin intermediate Staphylococcus aureus (VISA) and heterogenous-VISA. Infect Genet Evol. 2014 Jan;21: 575-82. doi: 10.1016/j.meegid.2013.03.047. Epub 2013 Apr 6.
[9]	Elvira A , Eleonora C , Stefania S, et al. New Antimicrobial Resistance Strategies: An Adaptive Resistance Network Conferring Reduced Glycopeptide Susceptibility in VISA[J]. Antibiotics (Basel, Switzerland), 2023, 12(4): 783-783.
[10]	刘明涛, 李慧, 燕小辉, 等. Walk突变致异质性万古霉素中介耐药金黄色葡萄球菌生物学特性研究[J]. 中华医院感染学杂志, 2020, 30(13): 1964-1969.
[11]	Shizhou W , Kaifeng L , Yunjie L , et al. Two-component signaling pathways modulate drug resistance of Staphylococcus aureus (Review)[J]. Biomedical reports, 2020, 13(2): 5-5.
[12]	Mahsa A , Leila A , Amir A . Investigation of Mutations and Expression Level of GraSR and WalKR Systems Associated with Vancomycin Non-Susceptibility in Methicillin-Resistant Staphylococcus aureus[J]. Molecular Genetics, Microbiology and Virology, 2024, 39(1): 65-73.
[13]	张柳英, 李映红, 简福霞, 等. GraSR通过MurC促进金黄色葡萄球菌中等耐受万古霉素的作用研究[J]. 重庆医科大学学报, 2024, 49(10): 1067-1073.
[14]	Hu Z, Rao Y, Liu L, et al. A Single Point Mutation in GraS Drives Co-Evolution of Vancomycin Resistance and Virulence in Staphylococcus aureus[J]. Microorganisms, 2026, 14(5): 1151-1151.
[15]	Ali L , Aziz A H M . Crosstalk involving two-component systems in Staphylococcus aureus signaling networks[J]. Journal of bacteriology, 2024, 206(4): 1-16.
[16]	Castro BE, Rios R, Carvajal LP, Vargas ML, Cala MP, León L, Hanson B, Dinh AQ, Ortega-Recalde O, Seas C, Munita JM, Arias CA, Rincon S, Reyes J, Diaz L. Multiomics characterization of methicillin-resistant Staphylococcus aureus (MRSA) isolates with heterogeneous intermediate resistance to vancomycin (hVISA) in Latin America. J Antimicrob Chemother. 2022 Dec 23;78(1): 122-132. doi: 10.1093/jac/dkac363. PMID: 36322484; PMCID: PMC10205466.
[17]	Elbediwi M , Rolff J . Metabolic pathways and antimicrobial peptide resistance in bacteria[J]. The Journal of antimicrobial chemotherapy, 2024, 79(7): 1473-1483.
[18]	Castro BE, Rios R, Carvajal LP, Vargas ML, Cala MP, León L, Hanson B, Dinh AQ, Ortega-Recalde O, Seas C, Munita JM, Arias CA, Rincon S, Reyes J, Diaz L. Multiomics characterization of methicillin-resistant Staphylococcus aureus (MRSA) isolates with heterogeneous intermediate resistance to vancomycin (hVISA) in Latin America. J Antimicrob Chemother. 2022 Dec 23;78(1): 122-132. doi: 10.1093/jac/dkac363. PMID: 36322484; PMCID: PMC10205466.
[19]	Castro BE, Rios R, Carvajal LP, et al. Multiomics characterization of methicillin-resistant Staphylococcus aureus (MRSA) isolates with heterogeneous intermediate resistance to vancomycin (hVISA) in Latin America[J]. Journal of Antimicrobial Chemotherapy, 2023, 78(1): 122-132.
[20]	Weile X , Dan L , Zhe W . Metabolic Analysis of the Mode of Action and Mode of Resistance for Novobiocin in Staphylococcus aureus[J]. Zoonoses, 2025, 5(1): 997-997.
[21]	刘彩林, 明亮. 异质性万古霉素中介金黄色葡萄球菌的流行性及mgrA基因对万古霉素耐药性影响的研究[J]. 中国抗生素杂志, 2020, 45(2): 175-180.
[22]	Safoura D , Masoumeh N , Fakhri H . Antibiotic susceptibility of human-associated Staphylococcus aureus and its relation to agr typing, virulence genes, and biofilm formation[J]. BMC infectious diseases, 2021, 21(1): 627-627.
[23]	Lai C H, Wong M Y, Huang T Y, et al. Exploration of agr types, virulence-associated genes, and biofilm formation ability in Staphylococcus aureus isolates from hemodialysis patients with vascular access infections[J]. Frontiers in cellular and infection microbiology, 2024, 14: 1-11.
[24]	Al-Hayali OZ, Al-Marjani MF, Maleki A. Controlling the Heterogeneous Vancomycin Intermediated Staphylococcus aureus (hVISA) Through the Use of Rosmarinus officinalis L. Leaves Extract[J]. Karbala International Journal of Modern Science, 2022, 8(4): 640-650.
[25]	Hardi P , Seema R. A genetic regulatory see-saw of biofilm and virulence in MRSA pathogenesis[J]. Frontiers in microbiology, 2023, 14(1): 1-30.
[26]	Cheng X , Shi Y , Liu Y, et al. Adaptive physiological and metabolic alterations in Staphylococcus aureus evolution under vancomycin exposure[J]. World Journal of Microbiology and Biotechnology, 2024, 40(10): 322-322.
[27]	Michelle S , H M D , Jessica P, et al. Effect of genetic background on the evolution of Vancomycin-Intermediate Staphylococcus aureus (VISA)[J]. PeerJ, 2021, 9(1): 1-25.
[28]	Jiang Y, Wang Y, Bai Y, Yuan L, Dai QB, Zhu Q, Zhao R, Liu MF, Liu P. Genomic and phenotypic adaptations of methicillin resistant Staphylococcus aureus during vancomycin therapy[J]. Sci Rep, 2025, 15(1): 15346-15346.
[29]	Fait A, Andersson DI, Ingmer H. Evolutionary history of Staphylococcus aureus influences antibiotic resistance evolution[J]. Current Biology, 2023, 33(16): 3389-3397.
[30]	Liang J, Hu Y, Fu M, Li N, Wang F, Yu X, Ji B. Resistance and Molecular Characteristics of Methicillin-Resistant Staphylococcus aureus and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus. Infect Drug Resist. 2023 Jan 23;16: 379-388.
[31]	Anna B , Jiabin H , Minyue Q, et al. Distinct clonal lineages and within-host diversification shape invasive Staphylococcus epidermidis populations[J]. PLoS pathogens, 2021, 17(2): 1-39.
[32]	Dehbanipour R , Maleki Z T V , Ghalavand Z . Colistin heteroresistance, mechanisms, diagnostic methods, and therapeutic options: A review[J]. Germs, 2025, 15(2): 166-188.
[33]	Gostev V, Kalinogorskaya O, Sopova J, Sulian O, Chulkova P, Velizhanina M, Tsvetkova I, Ageevets I, Ageevets V, Sidorenko S. Adaptive Laboratory Evolution of Staphylococcus aureus Resistance to Vancomycin and Daptomycin: Mutation Patterns and Cross-Resistance[J]. Antibiotics (Basel), 2023, 12(5): 928-928.
[34]	Yi YH, Wang JL, Yin WJ, Xu WH. Vancomycin or Daptomycin Plus a β-Lactam Versus Vancomycin or Daptomycin Alone for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections: A Systematic Review and Meta-Analysis. Microb Drug Resist. 2021 Aug;27(8): 1044-1056.
[35]	Yun JH, Chang E, Bae S, Jung J, Kim MJ, Chong YP, Kim S-H, Choi S-H, Lee S-O, Kim YS. Risk factors for vancomycin treatment failure in heterogeneous vancomycin-intermediate Staphylococcus aureus bacteremia. Microbiol Spectr. 2024 Aug 6;12(8): e0033324.
[36]	Mahmud A H , Wakeman A C . Navigating collateral sensitivity: insights into the mechanisms and applications of antibiotic resistance trade-offs[J]. Frontiers in Microbiology, 2024, 15(1): 1-19.
[37]	C K M , Taylor M , A M M, et al. The Emerging Role of β-Lactams in the Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections[J]. Antimicrobial agents and chemotherapy, 2020, 64(7): 1-14.
[38]	Wang Y, Sun Y, Chen G, et al. Emerging Antimicrobial Strategies Against Heterogeneous and Vancomycin-Intermediate Staphylococcus aureus[J]. International Journal of General Medicine, 2025, 18(1): 5329-5344.
[39]	王羽, 何昀珈, 殷海欣, 等. 金黄色葡萄球菌耐药机制与新型治疗策略研究进展[J]. 生物技术通报, 2026, 42(4): 53-64.
[40]	康艳华, 钟翌芃, 马强, 等. 血根碱联合β-内酰胺类抗生素对金黄色葡萄球菌的抗菌作用[J]. 中国兽医杂志, 2025, 61(3): 50-57.
[41]	Harigaya Y, Ngo D, Lesse AJ, Huang V, Tsuji BT. Characterization of heterogeneous vancomycin-intermediate resistance, MIC and accessory gene regulator (agr) dysfunction among clinical bloodstream isolates of staphyloccocus aureus. BMC Infect Dis. 2011 Oct 25;11: 287.
[42]	韩塔拉, 王俊瑞. 金黄色葡萄球菌异质性耐药机制及实验室检测技术[J]. 中国感染控制杂志, 2022, 21(12): 1249-1256.
[43]	胡远芳, 付明霞, 李娜, 等. 异质性万古霉素中介金黄色葡萄球菌和耐甲氧西林金黄色葡萄球菌的临床特征及耐药分析[J]. 滨州医学院学报, 2022, 45(2): 116-119+123.
[44]	胡远芳, 付明霞, 王凤霞, 等. 异质性万古霉素中介金黄色葡萄球菌的分子分型和同源性分析[J]. 中国抗生素杂志, 2023, 48(2): 222-227.
[45]	Howden BP, Davies JK, Johnson PD, Stinear TP, Grayson ML. Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Clin Microbiol Rev. 2010 Jan;23(1): 99-139.
[46]	Fatsis-Kavalopoulos N, Kim YK, Chong YP, Bae S, Lim SY, Kim YS, Andersson DI. Vancomycin heteroresistance (hVISA) in MRSA links to treatment failure and supports a revised PAP-AUC threshold[J]. Nat Commun, 2025, 16(1): 11251-11251.
[47]	Akiko H , Erino M , Ryo H, et al. Detection of antimicrobial impact on gram-negative bacterial cell envelope based on single-cell imaging by scanning electron microscopy[J]. Scientific Reports, 2023, 13(1): 11258-11258.
[48]	Amal A , Glenda W , Harry D, et al. Methicillin-resistant Staphylococcus aureus replication in the presence of high (≥32 µg/ml) drug concentration of vancomycin as seen by electron microscopy[J]. Journal of chemotherapy (Florence, Italy), 2020, 32(4): 179-187.
[49]	Guo Z, Peng H, Shang W, Yang Y, Hu Z, Rao Y, Huang X, Dou J, Xu Z, Rao X. WalK(S221P) Mutation Promotes the Production of Staphylococcus aureus Capsules Through an MgrA-Dependent Pathway[J]. Microorganisms, 2025, 13(3): 502-502.
[50]	Moller AG, Petit RA 3rd, Davis MH, Read TD. Development of an Amplicon Nanopore Sequencing Strategy for Detection of Mutations Conferring Intermediate Resistance to Vancomycin in Staphylococcus aureus Strains. Microbiol Spectr. 2023 Feb 14;11(1): e0272822.
[51]	On Y, Yoon EJ. Strategies for integrating whole-genome sequencing into antimicrobial resistance surveillance. BMC Genomics. 2026 Jun 4.
[52]	Frias-De-Diego A, Jara M, Lanzas C. Influence of Sequencing Technology on Pangenome-Level Analysis and Detection of Antimicrobial Resistance Genes in ESKAPE Pathogens. Open Forum Infect Dis. 2025 Mar 26;12(4): ofaf183.
[53]	Fenniri I, André C. When culture-based whole-genome sequencing can change management in severe ocular bacterial infections. mBio. 2026 May 13;17(5): e0065926.
[54]	郭祖文, 饶一凡, 彭华刚, 等. WalK(S221P)突变促进金黄色葡萄球菌荚膜产生的作用研究[J]. 陆军军医大学学报, 2023, 45(23): 2460-2466.
[55]	李伦, 张丽娜, 王兵, 等. 金黄色葡萄球菌对万古霉素的耐药性及耐药基因检测分析[J]. 安徽医药, 2023, 27(7): 1338-1342.
[56]	Salemi R, Zega A, Aguglia E, Lo Verde F, Pigola G, Stefani S, Cafiso V. Balancing the Virulence and Antimicrobial Resistance in VISA DAP-R CA-MRSA Superbug[J]. Antibiotics, 2022, 11(9): 1159-1159.
[57]	Xu Z, Wang Y, Sheng K, Rosenthal R, Liu N, Hua X, Zhang T, Chen J, Song M, Lv Y, Zhang S, Huang Y, Wang Z, Cao T, Shen Y, Jiang Y, Yu Y, Chen Y, Guo G, Yin P, Weitz DA, Wang Y. Droplet-based high-throughput single microbe RNA sequencing by smRandom-seq. Nat Commun. 2023 Aug 23;14(1): 5130.
[58]	Cheng X, Wang Z, Liu Y, Ma L, Wang Z, Qiao Y, Du W, Guo S, Chen D, Su J. Ultrahigh-throughput screening of heterogeneous vancomycin-intermediate Staphylococcus aureus based on fluorescence-activated droplet sorting. BMC Med. 2025 Nov 3;23(1): 599.
[59]	Reed P, Sorg M, Alwardt D, Serra L, Veiga H, Schäper S, Pinho MG. A CRISPRi-based genetic resource to study essential Staphylococcus aureus genes. mBio. 2024 Jan 16;15(1): e0277323.
[60]	Li W, Liu M, Oikonomou P, Blattman S, Berisa M, Paul F, Hettleman J, Gonzalez J, Hu Q, Chen H, Tavazoie S, Jiang W. The genetic landscape of antibiotic sensitivity in Staphylococcus aureus. Sci Adv. 2026 May 8;12(19): eaeb9875.
[61]	Dixit A, Parnas O, Li B, Chen J, Fulco CP, Jerby-Arnon L, Marjanovic ND, Dionne D, Burks T, Raychowdhury R, Adamson B, Norman TM, Lander ES, Weissman JS, Friedman N, Regev A. Perturb-Seq: Dissecting Molecular Circuits with Scalable Single-Cell RNA Profiling of Pooled Genetic Screens. Cell. 2016 Dec 15;167(7): 1853-1866. e17.
[62]	Cheng J, Lin G, Wang T, Wang Y, Guo W, Liao J, Yang P, Chen J, Shao X, Lu X, Zhu L, Wang Y, Fan X. Massively Parallel CRISPR-Based Genetic Perturbation Screening at Single-Cell Resolution. Adv Sci (Weinh). 2023 Feb;10(4): e2204484.

Relative Articles(20)

Relative Articles

[1]	Li ZHANG, Qinhong LI, Jiangli LI, Wenjuan SHEN, Zhuo YU, Peng CHEN. Research Progress on Mechanism and Imaging Evaluation of In-Stent Restenosis After PCI. Journal of Kunming Medical University,
[2]	Li ZHANG, Qinhong LI, Jiangli LI, Wenjuan SHEN, Zhuo YU, Peng CHEN. Research Progress on Mechanism and Imaging Evaluation of In-stent Restenosis after PCI. Journal of Kunming Medical University, doi: 10.12259/j.issn.2095-610X.S20260501
[3]	Ruo SHU, Huayou LUO, Lijun SONG, Yu GAO, Yan HOU, Xinfeng ZHANG, Ying LI. The Role of APOE in Drug Resistance of Colon Cancer Based on Bioinformatics and Cell Experiments. Journal of Kunming Medical University, doi: 10.12259/j.issn.2095-610X.S20250902
[4]	Yifan LIU, Xing LUO, Tianci SONG, Zhihui YANG. Research Progress on Targeted Therapy and Resistance Mechanisms of Malignant Melanoma. Journal of Kunming Medical University, doi: 10.12259/j.issn.2095-610X.S20250222
[5]	Zhaoyang CAO, Sijia LIU, Yaying YANG. Advancements of Radiomics in Coloractal Cancer. Journal of Kunming Medical University,
[6]	Xia XIAO, Xiaoxiao SONG, Xianhui GUO, Yujiao ZHANG, Yongna ZHAO, Yun LIU, Qian LI, Chunrui LUO, Fanwei QU. Analysis of Single and Multiple Latent Categories of Satisfaction with Online and Offline Teaching for Medical Students Studying in China. Journal of Kunming Medical University, doi: 10.12259/j.issn.2095-610X.S20230826
[7]	Chen Xiao Xing , Di Guang , Ge Jia Yun , Wei Dong , Shi Zhi Tian , Guo Zhi Tang , Wang Tao , Zhao Song Ling , Wang Lian Min , Wang Lin . . Journal of Kunming Medical University,
[8]	Lu Min Nan , Liu Jian Jun , Zhao Yu , Zhang Yu Wen , Deng Ju Qing , Yang Xue Fang , Hu Yue Xin . . Journal of Kunming Medical University,
[9]	Zhang Nan Yang , Pan Yu , Wu Guo Dong , Zeng Yue Qin , Chen Liang . . Journal of Kunming Medical University,
[10]	Qian Lu , Bian Li . Research Progress of EGFR Mutations in Lung Cancer and Targeted Drug Resistance Mechanisms. Journal of Kunming Medical University,
[11]	Hu Yu Chong , Lu Jing Kun , Cui Meng Yao . . Journal of Kunming Medical University,
[12]	Tang Jia Hua . Influence of Autologuous Blood Transfusion on Hemorheology and Fracture Healing in Patients Undergoing Spinal Operation. Journal of Kunming Medical University,
[13]	Cao Yi Hui , Li Juan , Zhao Xiao Nan , Ning De Ming , Luo Chun Rui , Xu Wen . Phylogenetic Analysis of Influenza B Hemagglutinin Gene in Yunnan from 2009 to 2014. Journal of Kunming Medical University,
[14]	Yang Zheng Hao . . Journal of Kunming Medical University,
[15]	Zhang Yong Chun . . Journal of Kunming Medical University,
[16]	Chen Lian Yong . . Journal of Kunming Medical University,
[17]	Qing Chen . . Journal of Kunming Medical University,
[18]	Yang Yin Feng . . Journal of Kunming Medical University,
[19]	Li Xiao Fei . . Journal of Kunming Medical University,
[20]	Hua Peng . . Journal of Kunming Medical University,